STK11 and neoplasm: According to this model, metformin owes its antitumor activity to the inhibition of lipogenic citrate production via the oxidative metabolism pathway (lipogenic processes are crucial for the synthesis of membranes and tumor cell proliferation) in mitochondria due to drug-induced depletion of Krebs cycle intermediates in an LKB1- and AMPK-independent manner.